Refills Review
Best for: patients seeking a single account across multiple cash-pay telehealth categories (GLP-1 + ED + hair growth) and willing to verify state coverage + steady-state pricing during the intake before committing
Refills (refills.com) is a LegitScript-certified online pharmacy and telehealth platform offering compounded GLP-1 weight-loss prescriptions (semaglutide, tirzepatide) alongside ED, hair growth, and daily wellness treatments. Provider claims operation across all 50 US states (with documented exclusion of certain regions). Pricing is gated behind the intake; site is Webflow-hosted with dynamic content. Free shipping; no insurance needed.
Medium confidence · Last verified 2026-05-09 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Refills is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Refills prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
✓ Pros
- •LegitScript Certified seal verbatim ('LegitScript certified online pharmacy' alt text on the certification logo)
- •Provider claims operation across all 50 US states (with disclosed exclusions)
- •Multi-category telehealth platform (GLP-1 weight loss + ED + hair growth + daily wellness) — single-account convenience for patients seeking multiple modalities
- •Free shipping disclosed publicly
- •No insurance needed framing — cash-pay transparency
- •Webflow-hosted modern marketing site with structured Organization JSON-LD (signals operational maturity)
✗ Cons
- •Steady-state monthly pricing for compounded semaglutide and tirzepatide NOT disclosed publicly — gated behind intake
- •Specific legal entity name + state of incorporation NOT publicly disclosed
- •Specific partner compounding pharmacy NOT named
- •Excluded state/region list (per the 'does not service the' caveat in their 50-state claim) NOT visible in marketing copy — patients should verify state coverage during intake
- •Brand-name GLP-1 lineup (Wegovy/Zepbound/Mounjaro/Ozempic/Foundayo) NOT addressed — compounded only
- •Lab work + ongoing-care touchpoints NOT clearly disclosed
- •Multi-category model (also operating in ED + hair) signals broad direct-to-consumer telehealth rather than a GLP-1-specialist platform
Ready to start with Refills?
See current pricing and start your free consultation.
Sources & methodology
Our Refills review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to Refills
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Refills?
See current pricing and start your free consultation.